Zurich, July 26 (Reuters) - The following are some of the main factors expected to affect Swiss stocks on Friday: COMPANY STATEMENTS * Galenica said Injectafer received US FDA approval for the treatment of iron deficiency anaemia. * Panalpina said it improved profitability in the second quarter. * Swissquote said it was expecting to see net new money of about 1 billion Swiss francs in 2013 after assets ...
To access this content simply register below now.
Registering is easy and allows you to:
- Access all WardsAuto.com public content and newswire stories
- Participate in forums
- Comment on articles
- Sign up for e-newsletters
And much more!